FDA — authorised 20 August 1963
- Application: NDA013157
- Marketing authorisation holder: LILLY
- Local brand name: ANHYDRON
- Indication: TABLET — ORAL
- Status: approved
🇺🇸 Ciclotiazide in United States
FDA authorised Ciclotiazide on 20 August 1963
Marketing authorisations
FDA — authorised 8 June 1982
- Marketing authorisation holder: PHARMACIA AND UPJOHN
- Status: approved
FDA — authorised 8 June 1982
- Application: NDA018173
- Marketing authorisation holder: PHARMACIA AND UPJOHN
- Local brand name: FLUIDIL
- Indication: TABLET — ORAL
- Status: approved
Ciclotiazide in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Neuroscience approved in United States
Frequently asked questions
Is Ciclotiazide approved in United States?
Yes. FDA authorised it on 20 August 1963; FDA authorised it on 8 June 1982; FDA authorised it on 8 June 1982.
Who is the marketing authorisation holder for Ciclotiazide in United States?
LILLY holds the US marketing authorisation.